Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 3Diabetes Mellitus, Type 2 3Pancreatic Neoplasms 2Neoplasms 2Breast Neoplasms 2Sleep Wake Disorders 1Rectal Neoplasms 1Lymphatic Metastasis 1Fatigue 1Depression 1Communicable Diseases 1

Interventions

Dipeptidyl-Peptidase IV Inhibitors 4Sulfonylurea Compounds 3Metformin 3Vildagliptin 2Sodium-Glucose Transporter 2 Inhibitors 2Sitagliptin Phosphate 2Rosiglitazone 2Pioglitazone 2Glucagon-Like Peptide-1 Receptor Agonists 2voglibose 1somapacitan 1semaglutide 1saxagliptin 1repaglinide 1miglitol 1metahexamide 1meglitinide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1desaminopancreozymin octapeptide 1alogliptin 1Urine Specimen Collection 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Diabetes Mellitus, Type 2 × Metformin × Clear all
NCT07628556 2026-06-05

Antidiabetic Medications and Risk of Cancer

University of Pecs

Completed
74,799 enrolled

Diabetes Mellitus, Type 2, Neoplasms

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
886,172 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT01195259 2013-10-28

Malignancy Meta Analysis for BRL49653

GlaxoSmithKline

Completed
1 enrolled

Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡